According to our (Global Info Research) latest study, the global Single Cell Isolation System market size was valued at US$ 813 million in 2025 and is forecast to a readjusted size of US$ 1577 million by 2032 with a CAGR of 10.0% during review period.
A Single Cell Isolation System is an instrument or integrated platform that identifies, sorts, dispenses, captures, partitions or physically retrieves individual cells from a suspension, adherent culture, colony, tissue section, droplet or microcapsule sample. The scope includes fluorescence-activated and image-based cell sorters, microfluidic single-cell dispensers and partitioning instruments, image-guided cell pickers, laser-capture microdissection systems and label-free functional or spectral isolation platforms; the main instrument, dedicated optical and fluidic modules, control computer, basic software and first-delivery configuration are counted as one system. Sequencers, downstream analyzers, cell counters, analysis-only cytometers, ordinary microscopes, population-scale magnetic separators, reagents, antibodies, beads, recurring cartridges, plates, tubes, software subscriptions and laboratory services are excluded. The 2025 ASP is US$247,882 per unit, global sales volume is approximately 3,187 units, and the estimated average gross margin is approximately 57%. The upstream chain includes lasers, cameras, microscopes, detectors, microfluidic chips, pumps, valves, motion stages, nozzles, sensors, control electronics and biocompatible materials; midstream activities include optical and fluidic design, image and signal processing, instrument assembly, software development, verification, sterilization compatibility, certification, calibration and application support; downstream users include pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostic laboratories, and contract research, development and testing organizations.
The market is moving from manual limiting dilution and microscope-guided pipetting toward automated, image-verified isolation. Buyers increasingly require evidence that each recovered well or compartment contains one viable cell.
Microfluidic systems are gaining share because they use small sample volumes, reduce shear stress and support disposable closed flow paths. Their compact format also lowers the operating threshold for laboratories that do not need a high-speed conventional sorter.
Imaging is becoming a core selection and quality-control layer. Brightfield and fluorescence records help confirm cell identity, exclude debris or doublets and document clonality in cell-line development.
Cell and gene therapy workflows are increasing demand for sterile, traceable and closed isolation. Regulated users favor audit trails, standardized recovery efficiency and integration with automated culture or analytical workflows.
Instrument purchases are increasingly evaluated on total operating cost. Cartridge prices, nozzle cleaning, service coverage, recovery yield and training time can matter as much as the initial system price, although recurring consumables are excluded from this market-size estimate.
Europe has strong demand from biopharmaceutical development, translational research and advanced therapy laboratories. Traceability, data integrity, biosafety and compatibility with regulated workflows are prominent purchasing criteria.
The Middle East is an emerging market led by genomics centers, research hospitals and national biotechnology programs. High-end systems remain import-dependent, so local application support and spare-parts availability strongly influence adoption.
Africa remains project-led, with demand concentrated in academic research, infectious-disease studies and cancer programs. South America is broader, led by Brazil and supported by oncology, immunology and agricultural biotechnology; both regions favor compact systems with manageable service requirements.
Report Scope
This report is a detailed and comprehensive analysis for global Single Cell Isolation System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single Cell Isolation System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single Cell Isolation System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single Cell Isolation System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single Cell Isolation System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Single Cell Isolation System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Single Cell Isolation System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton, Dickinson and Company, Sony Biotechnology Inc., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, Bio-Techne Corporation, CYTENA GmbH, NanoCellect Biomedical, Inc., Bruker Corporation, Sphere Bio Ltd., On-chip Biotechnologies Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Single Cell Isolation System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
anual or Operator-Guided
Semi-Automated
Fully Automated
Market segment by Single-Cell Throughput per Run
Below 100 Cells per Run
100–999 Cells per Run
1,000–9,999 Cells per Run
10,000 Cells or More per Run
Market segment by Optical Detection Channels
Brightfield Only
1–2 Fluorescence Channels
3–8 Fluorescence Channels
More Than 8 Fluorescence Channels
Market segment by Application
Biological Research Center
Hospital
Other
Major players covered
Becton, Dickinson and Company
Sony Biotechnology Inc.
Miltenyi Biotec B.V. & Co. KG
Sartorius AG
Bio-Techne Corporation
CYTENA GmbH
NanoCellect Biomedical, Inc.
Bruker Corporation
Sphere Bio Ltd.
On-chip Biotechnologies Co., Ltd.
Leica Microsystems GmbH
RareCyte, Inc.
Cell Microsystems, Inc.
Advanced Instruments, LLC
Yokogawa Electric Corporation
10x Genomics, Inc.
M20 Genomics (Hangzhou Yuezheng Biotechnology Co., Ltd.)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Single Cell Isolation System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Single Cell Isolation System, with price, sales quantity, revenue, and global market share of Single Cell Isolation System from 2021 to 2026.
Chapter 3, the Single Cell Isolation System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Single Cell Isolation System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single Cell Isolation System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Single Cell Isolation System.
Chapter 14 and 15, to describe Single Cell Isolation System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Single Cell Isolation System. Industry analysis & Market Report on Single Cell Isolation System is a syndicated market report, published as Global Single Cell Isolation System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Single Cell Isolation System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.